AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.380
-0.150 (-3.31%)
At close: Aug 28, 2025, 4:00 PM
4.600
+0.220 (5.02%)
After-hours: Aug 28, 2025, 7:44 PM EDT
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $131.57 million as of August 28, 2025. Its market cap has decreased by -43.41% in one year.
Market Cap
131.57M
Enterprise Value
160.46M
1-Year Change
-43.41%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since March 29, 2012, AVITA Medical's market cap has increased from $59.55M to $131.57M, an increase of 120.95%. That is a compound annual growth rate of 6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 136.07M | -59.76% |
| Dec 31, 2024 | 338.19M | -4.00% |
| Dec 29, 2023 | 352.28M | 111.74% |
| Dec 30, 2022 | 166.38M | -44.28% |
| Dec 31, 2021 | 298.61M | -25.68% |
| Dec 31, 2020 | 401.79M | -58.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 251.25B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |